AIS's Health Business Daily is a daily email newsletter with strategic business stories written by experienced AIS Health reporters, as well as other information of interest to health care business leaders — including news from the nation’s leading health insurers, developments from the federal and state governments that impact the health care industry, and exclusive datapoints from Subscribe now to get an issue delivered to your inbox every morning!
December 20, 2017
Headlines in the News
The New York Times, Dec. 18, 2017
Today's AIS Health Datapoint
41% ... of covered lives in the United States have access to Namenda XR, a drug used to treat dementia and Alzheimer's, on the preferred tier. Namenda XR is the most likely Alzheimer's drug to have preferred status across all formularies.
SOURCE: MMIT Analytics, as of Nov. 21, 2017
Subscribe to AIS's Health Plan Week

Quote of the Day
Even if a health insurer doesn’t have open information technology positions to fill, it “should be looking anyway. There’s that much change, so always be on the lookout.”
— Michelle Billingsley, senior vice president and chief delivery officer for Visiant and a former IT leader at Blue Cross Blue Shield of Michigan’s Blue Care Network, told listeners at a recent America’s Health Insurance Plans webinar.

The Featured Story of the day may be accessed on the day it is transmitted without logging in to Thereafter, you may need to log in to access the Featured Story. If you haven’t yet registered on, please take a minute to create a free account now and get free access to thousands of articles, blogs and much more.

Questions or suggestions about the content in AIS's HEALTH BUSINESS DAILY should be directed to Executive Editor Jill Brown at

AIS's HEALTH BUSINESS DAILY is copyrighted and protected by federal law. The re-use of its content is restricted (see below). However, you are permitted to forward this email to as many of your friends and colleagues as you wish, or better yet have them sign up for their own copy at atlantic_subscription.cfm

Copyright © 2017 Managed Markets Insight & Technology, LLC. All rights reserved. It is not permissible to include all or any portion of this content on any Web site, intranet or electronic network or in any print publication, without AIS's written permission in advance. Contact for more information.